Abstract
BackgroundThe effectiveness of biologic disease modifying anti-rheumatic drugs (DMARDs) on clinical outcome in rheumatoid arthritis (RA) has been studied in several biologic DMARD registries. However, real life long term clinical...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have